There is no such thing as type 1 diabetes; 'type 1' is a state of high sugar seen mainly in athletes with high needs; type 1 patients do not develop complications; insulin before puberty is a catastrophe (short stature, thyroid problems, cysts).

Original statement

لان ما فيش حاجه اسمها نوع اول اصلا

verbatim according to source. Translation by the project; the Arabic wording is authoritative.

Translation

There is no such thing as type 1 diabetes; 'type 1' is a state of high sugar seen mainly in athletes with high needs; type 1 patients do not develop complications; insulin before puberty is a catastrophe (short stature, thyroid problems, cysts).

Origin

Source status

Video transcript (own words)

Attribution

Elawady (machine transcript)

Video

حلقه علميه قويه تواجه التضليل العلمي بالحقيقه (Open source)

Published

17 April 2026

Timestamp

0:30:07 (location in the original video’s automatic YouTube caption track; confirms where the words occur, not who speaks)

Attribution uncertainty

Archive transcript (YouTube CC or AI-generated); no timestamps; 'published' is the date listed by the archive and may be the upload date. Live-stream transcripts can contain viewer comments read aloud; the quoted passage was checked in context to be spoken by Elawady.

Claimed mechanism

High glucose is an adaptive stress response (athletes, fighters), not insulin deficiency.

Claimed health effect

Denial of type 1 diabetes as a disease; insulin in children harmful

Population concerned

Children and adults with type 1 diabetes

Geographic restriction by Elawady

none found

Diverging source versions

Scientific assessment

False – The statement contradicts the robust evidence.

Certainty of evidence: high – Further research is very unlikely to change the assessment.

1. What was claimed?

Type 1 diabetes does not exist; it occurs in athletes; type 1 patients do not suffer complications; insulin before puberty is a catastrophe.

2. What is demonstrably correct?

Classification of diabetes types has become more detailed (e.g. LADA, MODY, gestational diabetes), which Elawady cites as proof of confusion; this refinement is real but reflects better diagnostics. Poorly controlled diabetes in children can impair growth.

3. What is wrong or exaggerated?

Type 1 diabetes is an autoimmune destruction of insulin-producing cells, leading to absolute insulin deficiency; without insulin it causes ketoacidosis and death. 'Insulin treatment is essential for individuals with type 1 diabetes' (ADA Standards 2026, I-ODD-16). Type 1 diabetes is not caused by sport. People with type 1 diabetes do develop retinopathy, nephropathy and neuropathy, and intensive insulin therapy reduced retinopathy by 76%, microalbuminuria by 39% and neuropathy by 60% in the DCCT (I-INS-03). Growth problems in children are caused by insulin deficiency and poor control, not by insulin.

4. What remains unclear?

Nothing material.

5. Which studies support it?

None.

6. Which studies contradict it?

I-INS-03, I-INS-07, I-INS-08, I-ODD-16.

7. What applies to Germany and Europe?

European (EASD) and German (DDG) guidance follow the same evidence base as the ADA/EASD consensus: individualised HbA1c targets, insulin as mandatory therapy in type 1 diabetes, and SGLT2 inhibitors/GLP-1 receptor agonists for people with cardiovascular or kidney disease. No country-specific difference changes the assessment.

8. What is known about Egypt?

Egypt has one of the highest diabetes prevalences in the region; the same drug classes and insulins are used. Access barriers and cost may make advice to stop medication attractive, which increases the practical risk of this claim. No Egypt-specific evidence changes the assessment.

9. What practical conclusion is appropriate?

Children and adults with type 1 diabetes need lifelong insulin. Any dietary approach can only be used in addition to insulin, under medical supervision.

Assessment details

Rationale for certainty of evidence

Type 1 diabetes as autoimmune beta-cell destruction with absolute insulin deficiency is among the best-established facts of medicine; before insulin was available (1922) it was fatal. Insulin is essential (ADA 2026). DCCT (RCT, 1,441 patients) proved that better insulin treatment reduces complications, which also contradicts 'no complications'.

Source quality

Several machine transcripts, consistent over 2025-2026.

Regional transferability

Universal.

Individual exceptions

None. Rare forms (e.g. MODY, some LADA) may initially not need insulin, but this requires specialist diagnosis.

Regional scope of the claim

general (biological/medical)

Last reviewed

25 October 2026 provisional

In plain language

Type 1 diabetes is a real disease in which the body's immune system destroys the cells that make insulin. Without insulin injections, people with type 1 diabetes, including children, become severely ill within days and can die. Insulin treatment protects their eyes, kidneys and nerves. Saying that type 1 diabetes does not exist is wrong and dangerous.

Studies on this claim

Regional context

Germany / EU

European (EASD) and German (DDG) guidance follow the same evidence base as the ADA/EASD consensus: individualised HbA1c targets, insulin as mandatory therapy in type 1 diabetes, and SGLT2 inhibitors/GLP-1 receptor agonists for people with cardiovascular or kidney disease. No country-specific difference changes the assessment.

Egypt

Egypt has one of the highest diabetes prevalences in the region; the same drug classes and insulins are used. Access barriers and cost may make advice to stop medication attractive, which increases the practical risk of this claim. No Egypt-specific evidence changes the assessment.

What applies in my country?

General scientific assessment

False Type 1 diabetes exists, is fatal without insulin, and insulin is essential at every age.

This statement concerns biological or medical relationships. The scientific assessment above applies regardless of the country; country-specific food data do not change it.

References

1. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.. Diabetes Control and Complications Trial Research Group; Nathan DM et al.. N Engl J Med 1993 · PMID 8366922 · DOI 10.1056/NEJM199309303291401
2. Hyperglycemic Crises in Adults With Diabetes: A Consensus Report.. Umpierrez GE et al.. Diabetes Care 2024 · PMID 39052901 · DOI 10.2337/dci24-0032
3. Diabetic ketoacidosis.. Dhatariya KK et al.. Nat Rev Dis Primers 2020 · PMID 32409703 · DOI 10.1038/s41572-020-0165-1
4. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes-2026.. American Diabetes Association Professional Practice Committee for Diabetes*. Diabetes Care 2026 · PMID 41358900 · DOI 10.2337/dc26-S009